DRNA

Dicerna Pharmaceuticals, Inc.
DRNA

Overview Fund Activity
Delisted

DRNA was delisted on the 27th of December, 2021.

Back to rankings

169 hedge funds and large institutions have $1.27B invested in Dicerna Pharmaceuticals, Inc. in 2019 Q4 according to their latest regulatory filings, with 67 funds opening new positions, 50 increasing their positions, 40 reducing their positions, and 9 closing their positions.

Holders
169
Holders Change
+57
Holders Change %
+50.89%
% of All Funds
3.34%
Holding in Top 10
4
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+33.33%
% of All Funds
0.08%
New
67
Increased
50
Reduced
40
Closed
9
Calls
$1.98M
Puts
$2.65M
Net Calls
-$667K
Net Calls Change
-$880K

Top Buyers

1
T. Rowe Price Associates
1
T. Rowe Price Associates
Maryland
$72.3M
2
Point72 Asset Management
2
Point72 Asset Management
Connecticut
$27.8M
3
DCM
3
Driehaus Capital Management
Illinois
$21.9M
4
Marshall Wace
4
Marshall Wace
United Kingdom
$21.6M
5
ACM
5
Aquilo Capital Management
California
$13.5M

Top Sellers

1
BCLSI
1
Bain Capital Life Sciences Investors
Massachusetts
$89.9M
2
Adage Capital Partners
2
Adage Capital Partners
Massachusetts
$8.81M
3
RCM
3
RA Capital Management
Massachusetts
$0
4
BI
4
BVF Inc
California
$0
5
BM
5
Bridger Management
New York
$43.7M
Name Market Value Shares Shares
Change 		Shares
Change %
RI
1
RTW Investments
New York
$129M 5,874,229 -328,196 -5%
BlackRock
2
BlackRock
New York
$97.7M 4,433,090 +66,597 +2%
BCLSI
3
Bain Capital Life Sciences Investors
Massachusetts
$89.9M 4,080,237 -3,250,000 -44%
EC
4
EcoR1 Capital
California
$79.9M 3,627,597 -335,381 -8%
T. Rowe Price Associates
5
T. Rowe Price Associates
Maryland
$72.3M 3,281,024 +2,004,112 +157%
Vanguard Group
6
Vanguard Group
Pennsylvania
$62.4M 2,832,199 +276,927 +11%
UBS Group
7
UBS Group
Switzerland
$48.3M 2,190,266 -244,273 -10%
Citadel Advisors
8
Citadel Advisors
Florida
$44.9M 2,039,923 +108,455 +6%
BM
9
Bridger Management
New York
$43.7M 1,981,633 -676,563 -25%
EAM
10
Eagle Asset Management
Florida
$38.7M 1,755,812 -9,344 -0.5%
State Street
11
State Street
Massachusetts
$36.5M 1,658,270 -124,675 -7%
Point72 Asset Management
12
Point72 Asset Management
Connecticut
$27.8M 1,260,216 +1,260,216 New
CTA
13
Carillon Tower Advisers
Florida
$24.7M 1,120,359 – –
Renaissance Technologies
14
Renaissance Technologies
New York
$21.9M 992,400 +507,000 +104%
DCM
15
Driehaus Capital Management
Illinois
$21.9M 991,920 +991,920 New
Marshall Wace
16
Marshall Wace
United Kingdom
$21.6M 979,870 +824,583 +531%
CS
17
Candriam SCA
Luxembourg
$19.4M 879,500 +160,000 +22%
Geode Capital Management
18
Geode Capital Management
Massachusetts
$17.3M 784,930 +61,805 +9%
Goldman Sachs
19
Goldman Sachs
New York
$16.8M 760,878 -22,139 -3%
Fidelity Investments
20
Fidelity Investments
Massachusetts
$15.9M 722,512 +54,564 +8%
EA
21
Emerald Advisers
Pennsylvania
$15.5M 701,341 -172,268 -20%
Northern Trust
22
Northern Trust
Illinois
$15.1M 687,251 -191 -0%
EMFAT
23
Emerald Mutual Fund Advisers Trust
Pennsylvania
$14.6M 661,052 -117,464 -15%
Millennium Management
24
Millennium Management
New York
$13.8M 625,910 +250,270 +67%
ACM
25
Aquilo Capital Management
California
$13.5M 614,436 +614,436 New
1
2 3 4 5